News Conference News EuroPCR 2025 FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI Yael L. Maxwell May 30, 2025
News Conference News EuroPCR 2025 Early Coronary Function Testing Improves Quality of Life in ANOCA Yael L. Maxwell May 28, 2025
News Conference News EuroPCR 2025 IVL Effective in Severely Calcified Lesions, Especially in Women Yael L. Maxwell May 22, 2025
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News EuroPCR 2024 Temporary Pacemaker After TAVI May Preclude Long-term Pacing Caitlin E. Cox May 24, 2024
News Conference News EuroPCR 2024 FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI Caitlin E. Cox May 20, 2024
News Conference News EuroPCR 2024 OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO Caitlin E. Cox May 16, 2024
News Conference News EuroPCR 2024 ORBITA-2: Angina Phenotype Strongly Predicts PCI Response Caitlin E. Cox May 15, 2024
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News EuroPCR 2022 Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities Caitlin E. Cox May 25, 2022
News Conference News EuroPCR 2021 Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate Caitlin E. Cox May 24, 2021
News Conference News EuroPCR 2021 The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages L.A. McKeown May 19, 2021
News Conference News EuroPCR 2020 DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions Todd Neale June 30, 2020
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Conference News EuroPCR 2019 Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers Caitlin E. Cox May 23, 2019